https://inventprise.com/2022/05/10/inventprise-inaugurates-manufacturing-facility-for-high-capacity-supply-of-pneumococcal-conjugate-vaccines/2023-01-15T20:22:35+00:00https://inventprise.com/2022/04/07/inventprise-inaugurates-manufacturing-facility-for-high-capacity-supply-of-pneumococcal-conjugate-vaccines-duplicate-7227/2023-01-15T20:15:15+00:00https://inventprise.com/2021/11/10/inventprise-inaugurates-manufacturing-facility-for-high-capacity-supply-of-pneumococcal-conjugate-vaccines-duplicate-7227-2/2023-01-19T17:41:49+00:00https://inventprise.com/2022/11/10/new-inventprise-pneumococcal-vaccine-enters-phase-1-2-clinical-evaluation/2023-01-15T20:20:17+00:00https://www.biospace.com/article/washington-biotech-wins-gates-backing-for-pneumococcal-vaccine-/#new_tab2023-01-18T19:12:24+00:00https://www.gatesnotes.com/Health/Pneumonia-vaccine#new_tab2023-01-18T19:14:28+00:00https://www.geekwire.com/2021/seattle-area-startup-inventprise-gets-backing-gates-foundation-pneumonia-shot/#new_tab2023-01-18T19:26:34+00:00https://www.precisionvaccinations.com/vaccines/pneumococcal-vaccines-2023#new_tab2023-01-19T16:54:06+00:00https://www.tandfonline.com/doi/full/10.1080/21645515.2022.2117949#new_tab2023-01-19T18:45:18+00:00https://cvia.cmail19.com/t/r-e-tjhyidkl-urcikztr-r/#new_tab2023-02-03T16:52:01+00:00http://inventprise.com/wp-content/uploads/2023/02/INVENT_web_Every-Breath-Counts-PCV-Scorecard.pdf#new_tab2023-02-12T21:33:57+00:00http://inventprise.com/wp-content/uploads/2023/02/INVENT_ISPPD-2022-PRECLINICAL-RESULTS-FOR-A-25-VALENT-PNEUMOCOCCAL-CONJUGATE-VACCINE-1.pdf#new_tab2023-02-06T02:07:48+00:00https://inventprise.com/2023/04/27/inventprise-ceo-attends-2nd-global-forum-on-childhood-pneumonia/2023-09-06T15:51:36+00:00https://inventprise.com/2024/01/02/inventprise-completes-vaccination-of-participants-in-a-phase-2-dose-ranging-study-of-its-25-valent-pneumococcal-vaccine-candidate/2024-01-02T16:41:27+00:00https://inventprise.com/2025/01/31/life-science-washington-welcomes-board-members/2025-02-03T19:58:29+00:00https://www.path.org/our-impact/articles/a-deadly-disease-for-infants-has-no-vaccinewere-changing-that/#new_tab2025-02-03T20:05:19+00:00https://inventprise.com/wp-content/uploads/2025/03/INVENTPRISE_Carroll-M-et-al_-Vaccine-54-126988-2025_-SARS-CoV-2-conjugate-vaccine-elicits-robust-immune-responses.pdf#new_tab2025-10-05T19:07:15+00:00https://inventprise.com/2025/05/15/inventprise-selects-quantoom-biosciences-ntensify-production-technology/2025-05-15T17:42:03+00:00https://inventprise.com/2025/06/24/inventprise-announces-breakthrough-in-covid-19-conjugate-vaccine-study-published-in-vaccine-journal/2025-06-24T16:15:52+00:00https://inventprise.com/2026/02/23/inventprise-announces-positive-interim-phase-1-2-results-for-hexavalent-maternal-group-b-strep-vaccine-candidate-ivt-gbs-06-presented-at-issad-2026/2026-02-24T00:35:16+00:00